Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 83635-12-5 | MDL No. : | MFCD09261379 |
Formula : | C7H14O3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VWGWOTXVWXTFMB-UHFFFAOYSA-N |
M.W : | 178.25 | Pubchem ID : | 10464888 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 43.7 |
TPSA : | 51.75 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.36 cm/s |
Log Po/w (iLOGP) : | 2.04 |
Log Po/w (XLOGP3) : | 1.45 |
Log Po/w (WLOGP) : | 2.31 |
Log Po/w (MLOGP) : | 1.06 |
Log Po/w (SILICOS-IT) : | 0.93 |
Consensus Log Po/w : | 1.56 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.53 |
Solubility : | 5.28 mg/ml ; 0.0296 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.14 |
Solubility : | 1.28 mg/ml ; 0.0072 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.75 |
Solubility : | 3.21 mg/ml ; 0.018 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.98 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | at 0 - 20℃; | [190] Step A: 1-Butyl cvclopropanesulfonateCyclopropanesulfonyl chloride (25g,178 mmol, leq) was dissolved in an excess of n-BuOH (80ml) and the reaction mixture was cooled at O0C, followed by the dropwise addition of pyridine (13.3ml, 160 mmol, 0.9eq). The mixture was slowly warmed to room temperature and stirred for 36 hours. The solvent was removed under reduced pressure and the resulting white solid was dissolved in chloroform. The organic phase was washed with water, brine and dried (MgSO4) and then concentrated to give an oil (24.5g, 77percent).1H NMR (400MHz, CDCl3) δ 4.25 (t, J= 6.4Hz, 2H), 2.47 (heptet, 2H), 1.74 (quintet, 2H), 1.43 (sextet, 2H), 1.24 (m, 2H), 1.08 (m, 2H), 0.96 (t, J = 7.6Hz, 3H); |
72% | With pyridine In dichloromethane at 0 - 25℃; for 16 h; | Cyclopropyl sulfonyl chloride (2 g, 14.2 mmol) was added drop-wise at 0° C. to a solution of Butylalcohol (2.1 g, 28.4 mmol) and Pyridine (2.35 g, 29.8 mmol) in DCM (20 mL) and continued stifling at 25° C. for 16 h. The reaction mixture was diluted with DCM (100 mL), washed with 1N aq.HCl solution followed by water and brine Organic layer collected was dried over anhydrous sodium sulphate and concentrated under reduced pressure to afford the Benzyl cyclopropanesulfonate (1.8 g, 72percent yield). 1H NMR (300 MHz, CD3OD) δ 4.3-4.1 (2H, t), 2.7-2.6 (1H, m), 1.8-1.6 (2H, m), 1.6-1.4 (2H, m), 1.2-1.1 (4H, m), 1.0-0.9 (3H, t) ppm. |
71% | at -10 - 0℃; | Step A: Butyl cyclopropanesulfonate:Cyclopropanesulfonyl chloride (5 g, 35 mmole, 1 eq) was dissolved in an excess BuOH (20 ml), the reaction mixture was cooled at -10 0C and pyridine (5.8 mL, 70 mmole, 2 eq) was slowly added dropwise. The mixture was slowly warmed at room temperature and stirred overnight. The solvent was removed under reduced pressure and the resulting white solid was dissolved in CHCl3. The organic phase was washed with water, brine and dried (MgSO4) and concentrated to give an oil (4.8 g, 24.9 mmole, 71percent). 1H NMR (300 MHz, CDCl3): δ 4.25 (t, 2H), 2.46 (m, 1H), 1.74 (m, 2H), 1.45 (m, 2H), 1.25 (dd, 2H), 1.09 (dd, 2H), .93 (t, 3H). |
71% | at -10 - 20℃; | Cyclopropanesulfonyl chloride (5 g, 35 mmol, 1 eq) was dissolved in an excess BuO l (20 ml), the reaction mixture was cooled at -10°C and pyridine (5.8 mL, 70 mmol, 2 eq) was slowly added dropwise. The mixture was slowly warmed at room temperature and stirred overnight. The solvent was removed under reduced pressure and the resulting white solid was dissolved in CHCI3. The organic phase was washed with water, brine and dried (MgS04) and concentrated to give an oil (4.8 g, 24.9 mmol, 71percent). i i NMR (300 MHz, CDCI3): δ 4.25 (t, 2H), 2.46 (m, 1H), 1.74 (m, 2H), 1.45 (m, 2H), 1.25 (dd, 2H), 1.09 (dd, 2H), .93 (t, 3H). |
[ 146475-51-6 ]
Isopropyl cyclopropanesulfonate
Similarity: 0.89
[ 186204-35-3 ]
(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane
Similarity: 0.62
[ 832142-14-0 ]
2-(1-((Methylsulfonyl)oxy)cyclopropyl)acetic acid
Similarity: 0.55
[ 25354-42-1 ]
Cyclopropyl trifluoromethanesulfonate
Similarity: 0.54
[ 146475-51-6 ]
Isopropyl cyclopropanesulfonate
Similarity: 0.89
[ 75732-43-3 ]
3-Benzyl-1,2-oxathiolane 2,2-dioxide
Similarity: 0.75